ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Panitumumab Improves PFS In Metastatic Colon Cancer

April 28, 2006

In Brief: Staff, Subcommittee Reports Due At NCAB June Meet; CCIRC to Sponsor Symposium On Epidemiology On Oct.

June 6, 1975

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

ASCO Is a Society In Transition, Growth; Major changes over Past Year

May 24, 1996